tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OTLK Stock Latest News

Unity Biotechnology appoints Tozier as Chief Strategy Officer
The FlyUnity Biotechnology appoints Tozier as Chief Strategy Officer
3d ago
UBX
OTLK
Outlook Therapeutics announces U.K. MHRA marketing authorization for LYTENAVA
PremiumThe Fly
Outlook Therapeutics announces U.K. MHRA marketing authorization for LYTENAVA
17d ago
OTLK
Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
PremiumPress Releases
Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
17d ago
OTLK
Outlook Therapeutics management to meet virtually with BTIG
PremiumThe Fly
Outlook Therapeutics management to meet virtually with BTIG
30d ago
OTLK
Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
PremiumPress Releases
Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
1M ago
OTLK
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
PremiumPress ReleasesOutlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
2M ago
OTLK
Outlook Therapeutics receives European Commission MA for LYTENAVA
PremiumThe Fly
Outlook Therapeutics receives European Commission MA for LYTENAVA
2M ago
OTLK
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
PremiumPress Releases
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
2M ago
OTLK
Outlook Therapeutics reports Q2 EPS ($8.01) vs. (52c) last year
PremiumThe Fly
Outlook Therapeutics reports Q2 EPS ($8.01) vs. (52c) last year
2M ago
OTLK
OTLK Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
OTLK Upcoming Earnings Report: What to Expect?
2M ago
OTLK
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
PremiumPress Releases
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
2M ago
OTLK
Outlook Therapeutics submits ONS-5010 MMA to MHRA for Wet AMD
PremiumThe Fly
Outlook Therapeutics submits ONS-5010 MMA to MHRA for Wet AMD
2M ago
OTLK
Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast
PremiumPress ReleasesOutlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast
3M ago
OTLK
Outlook Therapeutics® to Present at the Retina World Congress 2024
PremiumPress Releases
Outlook Therapeutics® to Present at the Retina World Congress 2024
3M ago
OTLK
Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
PremiumPress Releases
Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
3M ago
OTLK
Outlook Therapeutics files to sell 2.78M shares of common stock for holders
PremiumThe Fly
Outlook Therapeutics files to sell 2.78M shares of common stock for holders
3M ago
OTLK
Four new option listings on April 17th
PremiumThe Fly
Four new option listings on April 17th
3M ago
DBD
CXAI
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
PremiumPress Releases
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
3M ago
OTLK
Outlook Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Outlook Therapeutics files $300M mixed securities shelf
4M ago
OTLK
Spotify initiated, Lowe’s downgraded: Wall Street’s top analyst calls
PremiumThe FlySpotify initiated, Lowe’s downgraded: Wall Street’s top analyst calls
4M ago
V
FR
Outlook Therapeutics upgraded to Buy from Neutral at BTIG
PremiumThe Fly
Outlook Therapeutics upgraded to Buy from Neutral at BTIG
4M ago
OTLK
Outlook Therapeutics Grants Stock Options to Top Executives
PremiumCompany Announcements
Outlook Therapeutics Grants Stock Options to Top Executives
4M ago
8K
OTLK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >